Abiopharma

🔍 Mastrangelo Joe (Director)

Company: Eos Energy Enterprises, Inc. (EOSE)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 130,570 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,701,050.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 60,703 shares of Common Stock at $6.09 per share (Direct)
  Date: 2026-06-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,640,347.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 130,570 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 261,140.00 | transaction_form_type: 4 | Footnotes: F3, F1, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
• F2: Represents shares withheld from vested restricted stock unit ("RSU") award to satisfy tax obligations, as permitted by the Company's Amended and Restated 2020 Incentive Plan.
• F3: The reporting person received a grant of RSUs under the Issuer's 2020 Incentive Plan, which will vest in three equal installments on each of the first three anniversaries of the grant date, subject to continued service through each vesting date.
• F4: Not applicable.